NCT06510855View on ClinicalTrials.gov

DurAVR™ THV EU-EFS

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

October 31, 2030

Conditions
Symptomatic Aortic StenosisSevere Aortic Valve StenosisAortic Valve CalcificationAortic Valve FailureAortic Valve Disease
Interventions
DEVICE

DurAVR™ THV System

DurAVR™ THV System - Transcatheter Aortic Valve Implantation (TAVI) Procedure

Sponsors
All Listed Sponsors
lead

Anteris Technologies Ltd.

INDUSTRY